CY1110326T1 - Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους - Google Patents

Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους

Info

Publication number
CY1110326T1
CY1110326T1 CY20091100820T CY091100820T CY1110326T1 CY 1110326 T1 CY1110326 T1 CY 1110326T1 CY 20091100820 T CY20091100820 T CY 20091100820T CY 091100820 T CY091100820 T CY 091100820T CY 1110326 T1 CY1110326 T1 CY 1110326T1
Authority
CY
Cyprus
Prior art keywords
india
substituted tetralins
tetralins
substituted
tetralin
Prior art date
Application number
CY20091100820T
Other languages
English (en)
Inventor
Xiaoli Chen
Keith T Demarest
Jung Lee
Jay M Matthews
Philip J Rybczynski
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of CY1110326T1 publication Critical patent/CY1110326T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/56—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/61—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

Η παρούσα εφεύρεση παρουσιάζει παράγωγα της τετραλίνης και του ινδανίου, συνθέσεις που τα περιέχουν και μεθόδους χρησιμοποιήσεως τους ως ρυθμιστών PPAR-α για την αγωγή ή την αναστολή της εξελίξεως για παράδειγμα του διαβήτη.
CY20091100820T 2002-10-21 2009-08-04 Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους CY1110326T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42002602P 2002-10-21 2002-10-21
US49578803P 2003-08-15 2003-08-15
EP03773302A EP1554240B1 (en) 2002-10-21 2003-10-17 Substituted tetralins and indanes and their use

Publications (1)

Publication Number Publication Date
CY1110326T1 true CY1110326T1 (el) 2015-01-14

Family

ID=32179777

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100820T CY1110326T1 (el) 2002-10-21 2009-08-04 Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους

Country Status (28)

Country Link
US (2) US20040167211A1 (el)
EP (1) EP1554240B1 (el)
JP (1) JP4411275B2 (el)
KR (1) KR100989394B1 (el)
CN (1) CN100354259C (el)
AT (1) ATE430728T1 (el)
AU (1) AU2003279996B2 (el)
BR (1) BR0315623A (el)
CA (1) CA2502665A1 (el)
CY (1) CY1110326T1 (el)
DE (1) DE60327543D1 (el)
DK (1) DK1554240T3 (el)
EA (1) EA009554B1 (el)
ES (1) ES2325783T3 (el)
HR (1) HRP20050336B1 (el)
IL (1) IL168147A (el)
ME (1) MEP53108A (el)
MX (1) MXPA05004192A (el)
NO (1) NO332352B1 (el)
NZ (1) NZ539451A (el)
PL (1) PL376326A1 (el)
PT (1) PT1554240E (el)
RS (1) RS52079B (el)
SI (1) SI1554240T1 (el)
TW (1) TWI308563B (el)
UA (1) UA80561C2 (el)
WO (1) WO2004037779A1 (el)
ZA (1) ZA200504064B (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200500517A1 (ru) * 2002-10-21 2005-10-27 Янссен Фармацевтика Н. В. Лечение синдрома х замещёнными тетралинами и инданами
US20060247314A1 (en) * 2002-10-21 2006-11-02 Xiaoli Chen Substituted tetralins and indanes
US20060094786A1 (en) * 2002-10-21 2006-05-04 Xiaoli Chen Treating syndrome X with substituted tetralins and indanes
NZ539510A (en) * 2002-10-21 2008-01-31 Janssen Pharmaceutica Nv Substituted tetralin and indane derivatives
AR048931A1 (es) * 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis
WO2006044293A2 (en) * 2004-10-12 2006-04-27 Pharmacopeia Drug Discovery, Inc. Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
MX2015013365A (es) * 2013-03-20 2016-01-08 Hoffmann La Roche Derivados de urea y su uso como inhibidores de proteina de union de acidos grasos (puag).

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU632809B2 (en) * 1989-05-25 1993-01-14 Takeda Chemical Industries Ltd. Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof
GB9027023D0 (en) 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
DK0712387T3 (da) 1993-08-06 2000-05-29 Upjohn Co 2-Aminoindaner som selektive dopamin-D3-ligander
GB9606805D0 (en) 1996-03-30 1996-06-05 Glaxo Wellcome Inc Medicaments
EP1666587A1 (en) 1996-06-13 2006-06-07 Astellas Pharma Inc. Cyclic lipopeptide acylase
GB9822473D0 (en) 1998-10-16 1998-12-09 Glaxo Group Ltd Chemical compounds
US6300339B1 (en) 1998-10-21 2001-10-09 Novo Nordisk A/S Compounds, their preparation and use
TWI234557B (en) 1999-05-26 2005-06-21 Telik Inc Novel naphthalene ureas as glucose uptake enhancers
WO2001060807A1 (en) * 2000-02-18 2001-08-23 Merck & Co. Inc. Aryloxyacetic acids for diabetes and lipid disorders
IL155125A0 (en) * 2000-10-05 2003-10-31 Bayer Ag Propionic acid derivatives with ppar-alpha activating properties
WO2002044129A1 (fr) * 2000-11-29 2002-06-06 Kyorin Pharmaceutical Co., Ltd. Dérivés d'acide carboxylique substitués
AU2002222573A1 (en) * 2000-12-05 2002-06-18 Kyorin Pharmaceutical Co. Ltd. Substituted carboxylic acid derivatives
US7091225B2 (en) * 2000-12-20 2006-08-15 Smithkline Beecham Corporation Substituted oxazoles and thiazoles as hPPAR alpha agonists
TWI241190B (en) 2001-02-13 2005-10-11 Aventis Pharma Gmbh 4-Fluoro-N-indan-2-yl benzamide and its use as pharmaceutical
BR0207227A (pt) 2001-02-15 2004-02-10 Pfizer Prod Inc Compostos receptores ativados proliferadores ppar
CA2438551A1 (en) 2001-02-15 2002-08-22 Pfizer Products Inc. Ppar agonists
US6548538B2 (en) 2001-05-22 2003-04-15 Bayer Aktiengesellschaft Propionic acid derivatives
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
US20060247314A1 (en) * 2002-10-21 2006-11-02 Xiaoli Chen Substituted tetralins and indanes
US20060094786A1 (en) * 2002-10-21 2006-05-04 Xiaoli Chen Treating syndrome X with substituted tetralins and indanes
EA200500517A1 (ru) * 2002-10-21 2005-10-27 Янссен Фармацевтика Н. В. Лечение синдрома х замещёнными тетралинами и инданами
NZ539510A (en) * 2002-10-21 2008-01-31 Janssen Pharmaceutica Nv Substituted tetralin and indane derivatives
AR048931A1 (es) * 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis

Also Published As

Publication number Publication date
UA80561C2 (en) 2007-10-10
JP4411275B2 (ja) 2010-02-10
DE60327543D1 (de) 2009-06-18
MEP53108A (en) 2011-05-10
HRP20050336B1 (hr) 2013-06-30
ES2325783T3 (es) 2009-09-17
IL168147A (en) 2010-11-30
TWI308563B (en) 2009-04-11
PT1554240E (pt) 2009-06-17
WO2004037779A1 (en) 2004-05-06
AU2003279996B2 (en) 2009-07-09
KR100989394B1 (ko) 2010-10-25
ZA200504064B (en) 2006-09-27
EA200500516A1 (ru) 2005-10-27
CN1726187A (zh) 2006-01-25
KR20050071597A (ko) 2005-07-07
RS52079B (sr) 2012-06-30
AU2003279996A1 (en) 2004-05-13
PL376326A1 (en) 2005-12-27
RS20050320A (en) 2007-11-15
NO332352B1 (no) 2012-09-03
US7351857B2 (en) 2008-04-01
US20040167211A1 (en) 2004-08-26
EP1554240B1 (en) 2009-05-06
BR0315623A (pt) 2005-08-23
CN100354259C (zh) 2007-12-12
HRP20050336A2 (en) 2006-11-30
EA009554B1 (ru) 2008-02-28
CA2502665A1 (en) 2004-05-06
TW200418774A (en) 2004-10-01
ATE430728T1 (de) 2009-05-15
NO20052280L (no) 2005-06-24
DK1554240T3 (da) 2009-08-17
SI1554240T1 (sl) 2009-10-31
JP2006503917A (ja) 2006-02-02
MXPA05004192A (es) 2005-09-20
US20060074130A1 (en) 2006-04-06
NZ539451A (en) 2008-03-28
EP1554240A1 (en) 2005-07-20

Similar Documents

Publication Publication Date Title
CY1110326T1 (el) Υποκατασταθεισες τετραλινες και ινδανια και η χρηση τους
CY1110555T1 (el) 4-((φαινοξυαλκυλ)θειο)-φαινοξυοξεικα οξεα και αναλογα
NO20052277L (no) Behandling av syndrom X med substituerte tetraliner og indaner
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
SE0301653D0 (sv) Novel compounds
UY27668A1 (es) Composición de ziprasidona y controles sintéticos
NO20055741D0 (no) Nye kjemiske forbindelser
ECSP066536A (es) Derivados de acidos fenoxiaceticos utiles como agonistas dobles dereceptor activado por proliferador de peroxisoma
ATE421518T1 (de) Dihydrochinazolinone als 5ht-modulatoren
CY1111864T1 (el) Παραγωγα του ενζυμου που διεγειρει nf-καππαβ, παρασκευη αυτων και χρηση αυτων
ECSP077319A (es) Acidos 4-((fenoxialquil)tio)-fenoxiaceticos, y analogos de los mismos
CO2021004141A2 (es) Moduladores de la expresión de pnpla3
NI200700074A (es) Acidos 4-((fenoxialquil)tio)-fenoxiaceticos y analogos
ATE433458T1 (de) Modulatoren von ship-1
AU2003294253A8 (en) Emulsions including surface-modified organic molecules
CR7795A (es) Tetralinos e indanes sustitutos
TW200738244A (en) 20-Alkyl, gemini vitamin D3 compounds and methods of use thereof
BRPI0408117A (pt) compostos heterocìclicos bifuncionais e métodos de produção e uso dos mesmos
DK1656360T3 (da) Thiazolinderivater som selektive androgenreceptor-modulatorer
DE602004031053D1 (de) Azeotropartige zusammensetzungen, die hexafluorpropylendimer enthalten, und verwendung davon
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
UY29756A1 (es) Derivados de 5-piridazinil-1-azabiciclo(3.2.1) octano, su preparación y su aplicación en terapéutica.
ECSP003458A (es) Compuestos para tratar la obesidad
ECSP066627A (es) Indazol-o-glucosidos sustituidos
ECSP066628A (es) Indol-o-glucosidos sustituidos